Author
Listed:
- Christian Tetteh Duamor
- Fabrice Roberto Datchoua-Poutcheu
- Winston Patrick Chounna Ndongmo
- Aldof Tah Yoah
- Ernest Njukang
- Emmanuel Kah
- Mary Sheena Maingeh
- Jonas Arnaud Kengne-Ouaffo
- Dizzle Bita Tayong
- Peter A Enyong
- Samuel Wanji
Abstract
Introduction: The CDTI model is known to have enhanced community participation in planning and resource mobilization toward the control of onchocerciasis. These effects were expected to translate into better individual acceptance of the intervention and hence high Treatment Coverage, leading to a sustainable community-led strategy and reduction in the disease burden. A survey revealed that after 10–12 rounds of treatment, prevalence of onchocerciasis was still high in three drainage basins of South West Cameroon and transmission was going on. Methods: We designed a three (3)-year retrospective (2012, 2013 and 2014), descriptive cross-sectional study to explore the roles of operational challenges in the failure of CDTI to control the disease as expected. We administered 83 semi-structured questionnaires and conducted 12 in-depth interviews with Chiefs of Bureau Health, Chiefs of Centers, CDDs and Community Heads. Descriptive statistics was used to explore indicators of performance which were supported with views from in-depth interviews. Results: We found that community participation was weak; communities were not deciding time and mode of distributions. Only 6 (15.0%) of 40 Community Drug Distributors reported they were selected at general community meetings as required. The health service was not able to meet and discuss Community-Directed Treatment with Ivermectin activities with individual communities partly due to transportation challenges; this was mostly done through letters. Funding was reported to be inadequate and not timely. Funds were not available to conduct Community-Self Monitoring after the 2014 Mass Drug Administration. There was inadequate health staff at the frontline health facility levels, and some Chiefs of Center reported that Community-Directed Treatment with Ivermectin work was too much for them. The mean operational Community Drug Distributor-population ratio was 1 Community Drug Distributor per 317 populations (range: 194–464, expected is 1:250). Community Drug Distributor attrition rate was 14% (2012), 11% (2013) and 12% (2014) of total Community Drug Distributors trained in the region. Lack of incentive for Community Drug Distributor was primary reason for Community Drug Distributor attrition. Number of Community Drug Distributors trained together by health area ranged from 14 to 127 (mean ± SD = 51 ±32) with duration of training ranging from 4–7 hours (mean ± SD = 5.05 ± 1.09). The trainings were conducted at the health centers. Community Drug Distributors always conducted census during the past three distributions (Mean ± SD = 2.85 ± 0.58). Community-Self Monitoring was facing challenge. Several of the community heads, Chiefs of Bureau Health and Chiefs of Center agreed that Community-Self Monitoring was not being carried out effectively due to lack of incentives for monitors in the communities. Conclusion: Inadequate human resource, funding issues and transportation challenges during distribution periods reduced the ability of the health service to thoroughly sensitize communities and supervise CDTI activities. This resulted in weak community understanding, acceptance and participation in the process. CDTI in our study area did not achieve sustainable community-led campaign and this may have led to the reduced impact on Onchocerciasis. Author summary: River blindness is caused by a very tiny, thread-like worm. The disease is better controlled when affected communities are included in the planning and carrying out of distribution of Ivermectin used to treat the disease. For a community to be able to prevent people from getting this disease, members must take Ivermectin once or twice a year, continuously for about 20 years. Hence, the organization in charge of controlling river blindness (African Programme for Onchocerciasis Control–APOC) decided that when a control programme is started in a community, the community must be involved and assisted to take full charge of the programme so that within 12 years the community can sustain the distribution of Ivermectin for as long as necessary. This community directed strategy prevented river blindness in many communities. However, after 10–12 years of implementation, studies found that river blindness largely persists in communities in three drainage basins in South West Region of Cameroon. This paper discussed the operational challenges that the programme may have faced in these areas.
Suggested Citation
Christian Tetteh Duamor & Fabrice Roberto Datchoua-Poutcheu & Winston Patrick Chounna Ndongmo & Aldof Tah Yoah & Ernest Njukang & Emmanuel Kah & Mary Sheena Maingeh & Jonas Arnaud Kengne-Ouaffo & Dizz, 2017.
"Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon,"
PLOS Neglected Tropical Diseases, Public Library of Science, vol. 11(11), pages 1-18, November.
Handle:
RePEc:plo:pntd00:0005966
DOI: 10.1371/journal.pntd.0005966
Download full text from publisher
References listed on IDEAS
- Grace Fobi & Laurent Yameogo & Mounkaila Noma & Yaovi Aholou & Joseph B Koroma & Honorat M Zouré & Tony Ukety & Paul-Samson Lusamba-Dikassa & Chris Mwikisa & Daniel A Boakye & Jean-Baptist Roungou, 2015.
"Managing the Fight against Onchocerciasis in Africa: APOC Experience,"
PLOS Neglected Tropical Diseases, Public Library of Science, vol. 9(5), pages 1-9, May.
- Amazigo, Uche & Okeibunor, Joseph & Matovu, Victoria & Zouré, Honorat & Bump, Jesse & Seketeli, Azodoga, 2007.
"Performance of predictors: Evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control,"
Social Science & Medicine, Elsevier, vol. 64(10), pages 2070-2082, May.
Full references (including those not matched with items on IDEAS)
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pntd00:0005966. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosntds (email available below). General contact details of provider: https://journals.plos.org/plosntds/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.